Investegate |Formycon AG Announcements | Formycon AG: Formycon Concludes Collaboration and License Agreement with SCG Cell Therapy for its COVID-19 Drug FYB207 for the Asia Pacific Region
Investegate announcements from Formycon AG, Formycon Concludes Collaboration and License Agreement with SCG Cell Therapy for its COVID-19 Drug FYB207 for the Asia Pacific Region
Corporate Communications Cell Therapy Pte Ltd Hoc Announcement Concludes Collaboration License Agreement Asia Pacific
Source: investegate.co.uk